`

GemVax & KAEL

Biotechnology Research

Specialities :
Drug development
Biopharmaceutical
Peptide drug
Htert
Alzheimer's disease

+3

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About GemVax & KAEL

What does Gemvax & kael do?+

Since 2008, GemVax & KAEL has operated as a cutting-edge research and development company developing proprietary peptide drug, GV1001, for treatment against various cancers and neurodegenerative disease including Alzheimers disease and Progressive Supranuclear palsy. The fundamental driving purpose of our innovative pharmaceutical research is to facilitate significant improvements to human life through the introduction of advanced medical technology and innovation rooted in advanced scientific measures. At GemVax, we take pride in our proactive approach to medical research, and our progressive peptide-drug focused advancements have played a crucial role in the incessant global battle against incurable disease

What are Gemvax & kael's specialties? +

Drug development,biopharmaceutical,peptide drug,htert,alzheimer's disease,psp ,cancer,and bph

What is Gemvax & kael's industry? +

Gemvax & kael operates in the Biotechnology research industry.

What is Gemvax & kael's revenue? +

Gemvax & kael's revenue is 11m - 100m

What is Gemvax & kael's company size? +

Gemvax & kael has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.